Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Smilow Cancer Hospital Care Center at Guilford
Guilford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Yale
New Haven, Connecticut, United States
- Yale University, Yale Cancer Center
New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center at North Haven
North Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center at Trumbull
Trumbull, Connecticut, United States
- Smilow Cancer Hospital at Lawrence + Memorial Cancer Center
Waterford, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Cancer Care Specialists of Central Illinois-Crossroads Cancer Center
Effingham, Illinois, United States
- Cancer Care Specialists of Central Illinois-Swansea
Swansea, Illinois, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Michigan Oncology
Ann Arbor, Michigan, United States
- Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Wake Forest Medical Center
Winston-Salem, North Carolina, United States
- Strecker Cancer Center
Belpre, Ohio, United States
- Adena Regional Medical Center
Chillicothe, Ohio, United States
- Columbus Ncorp
Columbus, Ohio, United States
- Doctors Hospital
Columbus, Ohio, United States
- Grant Medical Center
Columbus, Ohio, United States
- Columbus Oncology and Hematology Associates, Inc.
Delaware, Ohio, United States
- Delaware Health Center Grady Cancer Center
Delaware, Ohio, United States
- Marietta Memorial Hospital
Marietta, Ohio, United States
- Marion General Hospital
Marion, Ohio, United States
- the Mark H. Sangmeister Center
Marion, Ohio, United States
- Knox Community Hospital
Mount Vernon, Ohio, United States
- Licking Memorial Hospital
Newark, Ohio, United States
- Southern Ohio Medical Center
Port Clinton, Ohio, United States
- Genesis Health Care Center
Zanesville, Ohio, United States
- Upmc Hillman Cancer at Upper St Clair
Bethel Park, Pennsylvania, United States
- Upmc Hillman Cancer Center at Mt. View
Greensburg, Pennsylvania, United States
- Ahn Cancer Institute at Jefferson
Jefferson Hills, Pennsylvania, United States
- Forbes Regional Hospital
Monroeville, Pennsylvania, United States
- Upmc Hillman Cancer Center at Monroeville
Monroeville, Pennsylvania, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Upci Hillman/shadyside
Pittsburgh, Pennsylvania, United States
- Upmc Cancer Center at Passavant Oha
Pittsburgh, Pennsylvania, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- Upmc Hillman Cancer Center at Passvant Hoa
Pittsburgh, Pennsylvania, United States
- Wpaon/medical Center Clinic
Pittsburgh, Pennsylvania, United States
- Western Pennsylvania Hospital Dba West Penn Hospital
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 May 2018
- Primary completion
- 22 Feb 2021
- Completion
- 30 Dec 2021
- Last update posted
- 20 Apr 2022
- Registered enrollment
- 45
- Registry id
- NCT03102047
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.